Literature DB >> 4140505

Sarcoma-virus-related RNA sequences in normal rat cells.

N Tsuchida, R V Gilden, M Hatanaka.   

Abstract

A rat type C virus spontaneously activated from the NRK (normal rat kidney) cell line was found to have two major size classes of viral RNA subunits sedimenting at 35 and 30 S. Virus-producing cells contained both RNA species, while normal "virus-free" rat cells contained primarily virus-specific 30S RNA species. A DNA transcript, specific for Kirsten sarcoma virus, prepared from virus activated in nonproducer BALB/c cells originally transformed by Kirsten sarcoma virus and rendered specific for the virus by absorption of sequences related to mouse helper virus hybridized only with the 30S RNA species of virus-producing rat cells and normal rat cells. These findings are consistent with the hypothesis that sarcoma-specific nucleic acid sequences in kirsten sarcoma virus emerged through a process that incorporated some portions of 30S RNA species from rat cells (either normal or virus-producing) into the Kirsten leukemia virus during passage in vivo of that virus. The virus designated M-MSV(RaLV), which originally derived from tumor induced by Moloney sarcoma virus (M-MSV) in rats, contained 35S RNA species of rat type C viruses and 30S RNA species specific for both rat and mouse viruses. It appears striking that for these two animal species, sarcoma-virus-specific information resides on a 30S subunit.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4140505      PMCID: PMC433915          DOI: 10.1073/pnas.71.11.4503

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  AN UNIDENTIFIED VIRUS WHICH CAUSES THE RAPID PRODUCTION OF TUMOURS IN MICE.

Authors:  J J HARVEY
Journal:  Nature       Date:  1964-12-12       Impact factor: 49.962

2.  Biochemical studies on adenovirus multiplication. 1. Stimulation of phosphorus incorporation into deoxyribonucleic acid and ribouncleic acid.

Authors:  M GREEN
Journal:  Virology       Date:  1959-11       Impact factor: 3.616

3.  Viral RNA of murine sarcoma virus produced by a hamster-mouse somatic cell hybrid.

Authors:  N Tsuchida; C Long; M Hatanaka
Journal:  Virology       Date:  1974-07       Impact factor: 3.616

4.  Spontaneous production of a C-type RNA virus in rat tissue culture lines.

Authors:  V Klement; M O Nicolson; W Nelson-Rees; R V Gilden; S Oroszlan; R W Rongey; M B Gardner
Journal:  Int J Cancer       Date:  1973-11-15       Impact factor: 7.396

5.  A virus-induced rhabdomyosarcoma of mice.

Authors:  J B Moloney
Journal:  Natl Cancer Inst Monogr       Date:  1966-09

6.  5-Bromo-2'-deoxyuridine potentiation of transformation of rat-embryo cells induced in vitro by 3-methylcholanthrene: induction of rat leukemia virus gs antigen in transformed cells.

Authors:  A E Freeman; R V Gilden; M L Vernon; R G Wolford; P E Hugunin; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

7.  Specificity of the DNA product of RNA-dependent DNA polymerase in type C viruses. II. Quantitative analysis.

Authors:  H Okabe; R V Gilden; M Hatanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

8.  Studies on the nucleic acid sequences of Kirsten sarcoma virus: a model for formation of a mammalian RNA-containing sarcoma virus.

Authors:  E M Scolnick; E Rands; D Williams; W P Parks
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

9.  Harvey sarcoma virus: a second murine type C sarcoma virus with rat genetic information.

Authors:  E M Scolnick; W P Parks
Journal:  J Virol       Date:  1974-06       Impact factor: 5.103

10.  Mutants of nonproducer cell lines transformed by murine sarcoma virus. 3. Detection and characterization of RNA specific for helper and sarcoma viruses.

Authors:  N Tsuchida; M Shih; R V Gilden; M Hatanaka
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

View more
  33 in total

1.  Quantitative analysis of the rescue of RNA sequences by mammalian type C viruses.

Authors:  R J Goldberg; R Levin; W P Parks; E M Scolnick
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

2.  Base sequence differences between the RNA components of Harvey sarcoma virus.

Authors:  J Maisel; E M Scolnick; P Duesberg
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

3.  Genetic variation in the RNA transcripts of endogenous virus genes in uninfected chicken cells.

Authors:  S Y Wang; W S Hayward; H Hanafusa
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

4.  In vitro translation of Harvey murine sarcoma virus RNA.

Authors:  W P Parks; E M Scolnick
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

5.  Rescue of endogenous 30S retroviral sequences from mouse cells by baboon type C virus.

Authors:  S A Sherwin; U R Rapp; R E Benveniste; A Sen; G J Todaro
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

6.  Presence of 5'-terminal cap structures in virus-specific RNA from feline leukemia virus-infected cells.

Authors:  A R Thomason; K H Friderici; L F Velicer; F Rottman
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

7.  Identification of a 30S RNA with properties of a defective type C virus in murine cells.

Authors:  R S Howk; D H Troxler; D Lowy; P H Duesberg; E M Scolnick
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

8.  Physical map of the Kirsten sarcoma virus genome as determined by fingerprinting RNase T1-resistant oligonucleotides.

Authors:  T Y Shih; H A Young; J M Coffin; E M Scolnick
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

9.  In vitro isolation of stable rat sarcoma viruses.

Authors:  S Rasheed; M B Gardner; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

10.  Induction of type C virions from normal rat kidney cells by 2-deoxy-D-glucose.

Authors:  E V Prochownik; S Panem; W H Kirsten
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.